COVID-19 treatments: authorised
2. September 2022 – The European Medicines Agency (EMA) published additional clinical data supporting the marketing authorisation of Veklury.
For more information, see here.
2. September 2022 – The European Medicines Agency (EMA) published additional clinical data supporting the marketing authorisation of Veklury.
For more information, see here.